Next Article in Journal
Synchrony 2022: Catalyzing Research and Treatments to Benefit Individuals with Neurodevelopmental Disorders including Autism Spectrum Disorders
Next Article in Special Issue
Bortezomib Pharmacogenetic Biomarkers for the Treatment of Multiple Myeloma: Review and Future Perspectives
Previous Article in Journal
Identifying Oxidized Lipid Metabolism-Related LncRNAs as Prognostic Biomarkers of Head and Neck Squamous Cell Carcinoma
Previous Article in Special Issue
Pharmacogenetics in the Treatment of Huntington’s Disease: Review and Future Perspectives
 
 
Article

Article Versions Notes

J. Pers. Med. 2023, 13(3), 489; https://doi.org/10.3390/jpm13030489
Action Date Notes Link
article pdf uploaded. 8 March 2023 16:39 CET Version of Record https://www.mdpi.com/2075-4426/13/3/489/pdf-vor
article xml uploaded. 9 March 2023 03:11 CET Original file -
article pdf uploaded. 9 March 2023 03:11 CET Updated version of record https://www.mdpi.com/2075-4426/13/3/489/pdf-vor
article html file updated 9 March 2023 03:12 CET Original file -
article xml uploaded. 9 March 2023 03:55 CET Update https://www.mdpi.com/2075-4426/13/3/489/xml
article pdf uploaded. 9 March 2023 03:55 CET Updated version of record https://www.mdpi.com/2075-4426/13/3/489/pdf
article html file updated 9 March 2023 03:56 CET Update -
article html file updated 20 March 2023 21:49 CET Update https://www.mdpi.com/2075-4426/13/3/489/html
Back to TopTop